Announcements Trials

Browse Landscape

Phase

Phase NA 8 Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 3 Colorectal Neoplasms 3 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Parkinsonian Disorders 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 High Grade Neuroendocrine Neoplasms 1

Interventions

Temozolomide 154 Bevacizumab 88 Radiotherapy 75 Radiation 23 Magnetic Resonance Spectroscopy 23 Lomustine 18 Irinotecan 18 pembrolizumab 17 Surgical Procedures, Operative 16 Carmustine 16 Erlotinib Hydrochloride 12 Nivolumab 11 Specimen Handling 10 Aminolevulinic Acid 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Carboplatin 9 Immunoglobulin G 7 Filgrastim 7 Etoposide 7 Drug Therapy 7 Disulfides 7 Cilengitide 7 Sunitinib 6 Sorafenib 6 O(6)-benzylguanine 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Blood Specimen Collection × Clear all

NCT01071837 2015-06-16

APG101 in Glioblastoma

Apogenix AG

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡